Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.
about
Acute decrease in HDL cholesterol associated with exposure to welding fumesLongitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypesVitamins C and E: beneficial effects from a mechanistic perspectiveThe Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular DementiaThe human paraoxonase gene cluster as a target in the treatment of atherosclerosisModulation of paraoxonases during infectious diseases and its potential impact on atherosclerosisValidation of PON1 enzyme activity assays for longitudinal studiesAssociation of organophosphate pesticide exposure and paraoxonase with birth outcome in Mexican-American womenHuman paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological rolesOne enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activityA maternal high-fat diet represses the expression of antioxidant defense genes and induces the cellular senescence pathway in the liver of male offspring ratsEvaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis.Paraoxonase 2 protein is spatially expressed in the human placenta and selectively reduced in labourExploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures.Formation of a vitamin C conjugate of acrolein and its paraoxonase-mediated conversion into 5,6,7,8-tetrahydroxy-4-oxooctanalIs alcohol beneficial or harmful for cardioprotection?Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR-/- mice.Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children.Association between paraoxonases gene expression and oxidative stress in hepatotoxicity induced by CCl4.HDL and cognition in neurodegenerative disorders.Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based study.Oxytocin induced oxidative stress in lactating Bubalis bubalis (Nili Ravi)Association between genetic polymorphisms and carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinomaImpact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.Novel associations of nonstructural Loci with paraoxonase activityHigh intrinsic aerobic capacity and pomegranate juice are protective against macrophage atherogenecity: studies in high- vs. low-capacity runner (HCR vs. LCR) ratsRelationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep SouthOxytocin ameliorates remote liver injury induced by renal ischemia-reperfusion in rats.Pomegranate for your cardiovascular healthThere is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study.Role of PON2 in innate immune response in an acute infection model.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Proteomic investigation of the time course responses of RAW 264.7 macrophages to infection with Salmonella entericaEffect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes--role of quercetin metabolism.PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model.Human paraoxonase-1 activity is related to the number of CD4+ T-cells and is restored by antiretroviral therapy in HIV-1-infected individuals.Targeting paraoxonase-1 in atherosclerosis.Homology modeling of human serum paraoxonase1 and its molecular interaction studies with aspirin and cefazolin.
P2860
Q23917930-C945E3B0-703F-4866-908E-AC9E888377DDQ24610194-FDBF6353-7326-4439-AB48-1AAEF61BA3ACQ24617202-DB6AD3D0-9E19-4176-8525-2EB9EC467EC3Q26795415-A7C9D22F-31CC-4C60-AACD-7FA9F9A9F193Q26824356-2E4822FD-9C13-4537-A3DA-AFDBDF913EE8Q27004131-E1E7B0E2-35C8-4E04-9E72-61A292FC4CD0Q28388799-57D9404C-854A-4A23-9A59-8CC162D68201Q28391420-84A9F39D-1BD9-4088-929E-0F6D65815BCDQ28395898-4385EE76-71AB-4264-9D7F-A00CB22B156CQ28397498-6F86F347-2483-4999-90A2-14B353D8241AQ28572031-934E4D34-5D4B-4F4F-A397-013CA4BDC410Q30441413-61EFE4EF-0848-4B9C-A1FD-4A698E51283BQ33590383-E35B71F3-9AB4-443F-A935-C8BBA1DB7B5AQ33709890-0FAE12AA-05C9-43F8-84B8-5ED14F1FDCFCQ33806503-F1B5E2BE-528C-4097-BA24-FF0AA6E7F4C0Q33911138-F3F96F6C-3CD6-4A44-80B1-1E3DC43C7516Q34088392-EB7C8934-9B12-4AB9-9756-AB05012E6682Q34414287-8FB18838-F514-4ABA-8A1D-8F63463A4A0EQ34590741-49BCA6F3-9AD1-48F7-BE6A-FC2F59870197Q34614842-EB45625C-6891-46CD-94BB-E91DF95BDFBEQ34776226-C4A55A29-844D-4F0C-8708-6B95642FD026Q34974966-9894A80A-AB01-4201-BBF0-A8A347712090Q35094777-ABAACBE3-ED8C-429E-9E89-0F7DA4338852Q35567828-536789F9-47B9-4738-971D-7D1973801EB9Q35615662-D10B3A22-A44C-46BC-B1B9-8A8EE85B9BDDQ35737661-68C0DBAD-06A7-4836-8DFA-267B76A65494Q35936649-CE3AD138-274B-4DE6-B4F3-A8D9BCEAFEF9Q36083392-C2E062DE-ABAF-4B51-A78D-3C5CB781961BQ36755341-544E9F39-0F4A-47C7-9A52-E6D4E332EB6AQ36789236-91A446FF-1D31-4E61-801D-ACE460D32E6BQ36919245-0254E129-A9BE-436E-9E8F-FA858BE76D6BQ36996548-2AD41BC8-AB11-474B-BF98-94CCDEDAE731Q37238748-2E2D0D23-098C-47B8-BFB6-266527A00C5DQ37254899-44AD84E1-D2D8-4756-8A4C-37754AFBC51AQ37274847-5C15C0F5-B0EF-432B-8F78-A06786D272D5Q37403048-1DED0ADB-4DC7-4BC4-BFA3-F552EDA55B17Q37509810-5026ACB0-3634-4191-96A3-7022108164DAQ37639821-D3203E21-03E9-4386-98EB-903DC82E6457Q38097853-98AD6F7D-6FB7-4F87-877C-379D2709E05BQ38450180-606A7038-FF27-4072-BCD3-CF918B1FC3EB
P2860
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Paraoxonases 1, 2, and 3, oxid ...... g atherosclerosis development.
@ast
Paraoxonases 1, 2, and 3, oxid ...... g atherosclerosis development.
@en
type
label
Paraoxonases 1, 2, and 3, oxid ...... g atherosclerosis development.
@ast
Paraoxonases 1, 2, and 3, oxid ...... g atherosclerosis development.
@en
prefLabel
Paraoxonases 1, 2, and 3, oxid ...... g atherosclerosis development.
@ast
Paraoxonases 1, 2, and 3, oxid ...... g atherosclerosis development.
@en
P1476
Paraoxonases 1, 2, and 3, oxid ...... g atherosclerosis development.
@en
P2093
Michael Aviram
Mira Rosenblat
P304
P356
10.1016/J.FREERADBIOMED.2004.06.030
P577
2004-11-01T00:00:00Z